Cargando...

Bacille-Calmette-Guerin non-responders: how to manage

Intravesical immunotherapy with bacille-Calmette-Guerin (BCG) is indicated in the treatment of high-risk and intermediate-risk non-muscle invasive bladder cancer (NMIBC). Our goal is to describe the various disease states following induction and maintenance BCG and to describe contemporary treatment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transl Androl Urol
Autores principales: von Rundstedt, Friedrich-Carl, Lerner, Seth P.
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4708234/
https://ncbi.nlm.nih.gov/pubmed/26816828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2015.05.03
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!